ライフサイエンスコーパス: operative mortality

1 ospital or within 30 days of operation (1.4% operative mortality).

2 outcome measures after CRC procedures beyond operative mortality.

3 es in the oldest old is focused primarily on operative mortality.

4 tal perioperative blood product exposure and operative mortality.

5 nt has a statistically significant effect on operative mortality.

6 edicts longer hospital stay and greater post-operative mortality.

7 that patient's SES is a strong predictor of operative mortality.

8 septal myectomy but does not influence post-operative mortality.

9 al treatment is often denied because of high operative mortality.

10 itate the assessment of strategies to reduce operative mortality.

11 sage in elderly patients, and lower adjusted operative mortality.

12 curred preoperatively may reduce the risk of operative mortality.

13 (MBO) and to identify risk factors affecting operative mortality.

14 ery by developing statistical risk models of operative mortality.

15 etermine whether race affected risk-adjusted operative mortality.

16 Elective aortic-root replacement has a low operative mortality.

17 = 0.001]) were associated independently with operative mortality.

18 (2%) underwent orthopedic procedures with no operative mortality.

19 There was no 30-day operative mortality.

20 ndependently associated with improvements in operative mortality.

21 rmine the minimum surgeon volume for optimum operative mortality.

22 important target for the second ITA lowered operative mortality.

23 e to rescue helps surgeons predict and avoid operative mortality.

24 njury, surgical revision, mediastinitis, and operative mortality.

25 There was no operative mortality.

26 There were no operative mortalities.

27 6+/-5% versus 48+/-4%, P<0.0001), with lower operative mortality (0.5% versus 5.4%, P=0.003) and bett

28 Surgical outcomes and operative mortality (1.4% versus 1.4%; P=1.00) were not

29 ations between matched SIMA and BIMA groups (operative mortality, 10 of 414 [2.4%] versus 13 of 414 [

30 nt artery was associated with higher risk of operative mortality (2.4% vs. 0.51%; p = 0.007).

31 requiring intervention, and there was 1 peri-operative mortality (2.5%).

32 entilation (17.6% versus 4.8%, P<0.001), and operative mortality (4.8% versus 0.6%, P=0.001).

33 ncreased age was also associated with higher operative mortality (4.83% for >or=75 years vs. 1.09% fo

34 erative complexity must be added to estimate operative mortality accurately.

35 sing logistic regression models, we compared operative mortality across surgeon subspecialties, adjus

36 d and grouped into quintiles according to 1) operative mortality (adjusted for patient characteristic

37 s were significant independent predictors of operative mortality (adjusted odds ratio 5.5, p = 0.036)

38 mes differ between IMG and USMG surgeons for operative mortality [adjusted mortality, 7.3% for IMGs v

39 to evaluate the association between race and operative mortality after AVR or MVR.

40 lack race was not a significant predictor of operative mortality after AVR or MVR; however, black rac

41 Black race is an independent predictor of operative mortality after CABG except for very high-risk

42 whether race is an independent predictor of operative mortality after coronary artery bypass graft (

43 n shown to be an independent risk factor for operative mortality after coronary artery bypass graftin

44 ace is an independent predictor of increased operative mortality after coronary artery bypass surgery

45 fined race as an independent risk factor for operative mortality after coronary artery bypass surgery

46 There was a 70% reduction in operative mortality after EVAR compared with open repair

47 not appear to be a significant predictor of operative mortality after isolated AVR or MVR; however,

48 Operative mortality after TASP implementation fell to 2.

49 ls have been developed to accurately predict operative mortality after valve replacement surgery.

50 Operative mortality also decreased with time.

51 Temporal trends showed that risk of operative mortality, although higher in elderly patients

52 Improvements in length of stay and in operative mortality among elderly patients suggest areas

53 Operative mortality among nursing home residents was sub

54 We had zero operative mortalities and a 10.3% morbidity rate.

55 Moreover, 30-day operative mortality and 12-month mortality were acceptab

56 The primary outcomes were operative mortality and a composite outcome (1 or more o

57 ample were used to measure the likelihood of operative mortality and a prolonged length of stay (LOS)

58 val rate of 43% and 52% respectively with no operative mortality and acceptable perioperative morbidi

59 Operative mortality and actuarial survival were determin

60 Endovascular repair has lower operative mortality and complications and has replaced s

61 like relationship between surgeon volume and operative mortality and determine the minimum surgeon vo

62 tatistically significant association between operative mortality and either treatment group (odds rat

63 air is being explored, with surprisingly low operative mortality and encouraging intermediate results

64 Operative mortality and long-term survival are presented

65 We compared the operative mortality and long-term survival between 16 88

66 lve repairability and postoperative outcome (operative mortality and long-term survival; all p < 0.00

67 ese patients has been associated with higher operative mortality and lower long-term survival.

68 Outcomes including operative mortality and major morbidity were recorded.

69 sed to determine the association of GFR with operative mortality and morbidities (stroke, reoperation

70 R was one of the most powerful predictors of operative mortality and morbidities.

71 In addition, the operative mortality and morbidity are far in excess of t

72 s have resulted in a significant decrease in operative mortality and morbidity for older patients.

73 15 level is an independent predictor of post-operative mortality and morbidity in cardiac surgery pat

74 eling was performed to provide risk-adjusted operative mortality and morbidity odds ratios.

75 Operative mortality and morbidity rates were 9% and 31%,

76 version to on-pump have significantly higher operative mortality and morbidity than either completed

77 Operative mortality and morbidity, and disease-free surv

78 Surgical indications, operative mortality and morbidity, and hematological out

79 uation of outcomes cannot be limited to only operative mortality and morbidity.

80 nt long-term relief of symptoms with minimal operative mortality and morbidity.

81 ed over time, with significant reductions in operative mortality and perioperative complications.

82 Variables associated with the end points of operative mortality and postoperative SCI were assessed

83 on models, we examined the relations between operative mortality and surgeon volume and hospital volu

84 n between older donor age and increased post-operative mortality and TCAD, it is more beneficial in t

85 Given their high risk of post-operative mortality and the diversity of preferences fou

86 egression was used to identify predictors of operative mortality and to estimate weights for an addit

87 We compared operative mortality and use of invasive interventions (m

88 ation >24 hours, stroke, re-exploration, and operative mortality) and 90-day risk-adjusted, price-sta

89 Age at operation had no effect on operative mortality, and late mortality was significantl

90 e, we examined isolated CABG surgery volume, operative mortality, and the composite end point of oper

91 Primary outcomes examined included operative mortality, aneurysm rupture, aneurysm-related

92 w transvalvular mean gradient, and increased operative mortality, aortic valve replacement was associ

93 ved associations between hospital volume and operative mortality are largely mediated by surgeon volu

94 Operative mortality associated with valve replacement su

95 e total years of life lost (YLL) due to post-operative mortality averted over a 3 year period; conver

96 Operative mortality before TASP implementation was 33.9%

97 The main outcome measure was operative mortality (before discharge or within 30 days

98 surgery, MV repair was associated with lower operative mortality, better long-term survival, and fewe

99 resection rate, number of nodes examined or operative mortality between gastrectomy and esophagectom

100 Absolute differences in operative mortality between VLVH and VHVH were somewhat

101 Of the 84 patients, there were 2 operative mortalities both in class IV aortic patients f

102 There was no operative mortality, but permanent pacing was needed in

103 Surgery for post-MI PMR involves a notable operative mortality, but there are recent trends for low

104 A risk model for operative mortality (c-index 0.81) revealed a risk-adjus

105 ons for the mortality analysis), we compared operative mortality, complications, and length of stay (

106 each of the 4 procedures, adjusted rates for operative mortality, complications, and readmissions wer

107 transfusion was an independent predictor of operative mortality, complications, major complications,

108 r adjustment, there was no relationship with operative mortality, complications, major morbidity, a m

109 Although operative mortality continues to decrease over time, spe

110 ed the extent to which racial differences in operative mortality could be accounted for by the hospit

111 , and comorbid conditions, the risk-adjusted operative mortality (death before discharge or within 30

112 logistic regression to assess differences in operative mortality (death within 30 days or before disc

113 Operative mortality declined during the study period for

114 Operative mortality declined for all eight procedures, r

115 Although operative mortality decreased from 4.1% to 2.9% (adjuste

116 an increase in concomitant major procedures, operative mortality decreased from approximately 4% in t

117 However, total pancreatectomy operative mortality decreased over time (1970-1989, 40%;

118 atient risk and clustering effects, rates of operative mortality decreased with increasing hospital C

119 Operative mortality (defined as a death occurring within

120 ailure, reoperation for bleeding, stroke, or operative mortality did not differ in the two groups.

121 Disparities in operative mortality due to socioeconomic status (SES) ha

122 The magnitude of the volume-operative mortality effect varied from an adjusted odds

123 tries with the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME) randomized tria

124 ncluded in the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME) randomized tria

125 fairs AWESOME (Angina With Extremely Serious Operative Mortality Evaluation) study randomized trial a

126 Influence of beta-blockers on operative mortality, examined using both direct risk adj

127 amine the effect of subspecialty training on operative mortality following lung resection.

128 reported on 30-day mortality or in-hospital/operative mortality following valve surgery and that com

129 Surgeon volume was inversely related to operative mortality for all eight procedures (P=0.003 fo

130 Finally, operative mortality for isolated tricuspid valve surgery

131 risk factors were the major determinants of operative mortality for most civilian surgical cases.

132 Unadjusted operative mortality for MVR only was 5.60% for blacks ve

133 Patient risk factors alone accounted for operative mortality for operations less than level 4 (95

134 ational study demonstrates an improvement in operative mortality for patients undergoing pancreatecto

135 ents also experienced higher rates of 30-day operative mortality (>80 years vs. 45-55 years; 6% vs. <

136 isk surgery have changed as a result and how operative mortality has been affected.

137 ver, despite an increase in surgical volume, operative mortality has not changed.

138 Operative mortality has traditionally been assessed at 3

139 established, relationships between race and operative mortality have not been assessed systematicall

140 Along with lower operative mortality, HVHs have better late survival rate

141 gitation can be performed with an acceptable operative mortality if patients undergo surgery before t

142 The rate of operative mortality in appropriately selected patients i

143 Using national Medicare files, we examined operative mortality in approximately 461,000 patients un

144 al features and outcomes or risk factors for operative mortality in cardiogenic shock (CS) patients u

145 on, was associated with significantly higher operative mortality in comparison with patients with non

146 Operative mortality in CS patients was high and surgery

147 care database (1994 to 1999), we studied the operative mortality in patients undergoing 4 cardiovascu

148 We then compared operative mortality in patients undergoing surgery at ve

149 and reoperation are predictors of increased operative mortality in patients with ventricular dysfunc

150 om liver failure in the non-PVE group and no operative mortality in the PVE group.

151 significant association between CON law and operative mortality in the South.

152 ospital CABG procedural volume and all-cause operative mortality (in-hospital or 30-day, whichever wa

153 41-50 years, 51-60 years, and >60 years) and operative mortality (in-hospital or within 30 days), adj

154 bility of curative resection with negligible operative mortality, incidental MD is best treated with

155 An acceptable operative mortality, increased and improved quality of l

156 Some, but not all, of this variation in operative mortality is attributable to hospital and surg

157 tic aneurysms smaller than 5.5 cm, even when operative mortality is low.

158 n of women are not offered intervention, and operative mortality is much higher in women for both EVA

159 The relationship between age and operative mortality is not linear, manifesting a steeper

160 rse relationship between hospital volume and operative mortality is well-established for esophageal,

161 ital volume may be an important predictor of operative mortality, it is not associated with resource

162 Operative mortality (< or =30 days) in the extracted stu

163 rated on in advanced repair centres with low operative mortality (<1%) and high repair rates (>/=80-9

164 midsternotomy, no renal failure, strokes, or operative mortality (<30 days), transient ischemic attac

165 tality and a composite outcome (1 or more of operative mortality, major adverse event, prolonged hosp

166 Case mix-adjusted operative mortality, major complications, and postoperat

167 val, (3) reintervention rate, and (4) 30-day operative mortality, morbidity, and wound and access com

168 one patients (17.0%) had a complication, and operative mortality occurred in 27 patients (mortality r

169 dentified CAD as an independent predictor of operative mortality (odds ratio [OR] = 2.35, P = 0.012),

170 and PLF group were independent predictors of operative mortality (odds ratio [OR]: 1.18, p < 0.05; an

171 rtery bypass graft was associated with lower operative mortality (odds ratio, 0.18; 95% CI, 0.04 to 0

172 70 years of age demonstrated a reduction in operative mortality (odds ratio, 0.80 per year after reg

173 associated with higher risk-adjusted odds of operative mortality (odds ratio, 4.06; 95% CI, 3.60-4.58

174 R, the presence of LGE predicted higher post-operative mortality (odds ratio: 10.9; 95% confidence in

175 e or two units or more than two units had an operative mortality of 2.5% and 11.1%, respectively, com

176 e findings were obtained despite a low total operative mortality of 2.7 percent in the immediate-repa

177 Operative mortality of the 3 age groups (1.2%, 4.1%, and

178 Women have a higher operative mortality (OM) after coronary artery bypass gr

179 ot associated with significant reductions in operative mortality or complications.

180 Patients with operative mortality or incomplete resection (R2) were ex

181 ve mortality, and the composite end point of operative mortality or major morbidity for the years 200

182 Historical measures of operative mortality or procedure volume identify hospita

183 e anatomic site without substantial risk for operative mortality or recurrent infection.

184 Peri-operative mortality (OR 0.81, 95% CI 0.34-1.93; p=0.63)

185 t speed remained independently predictive of operative mortality (OR, 1.11 per 0.1-m/s decrease in ga

186 Thus, operative mortality (overall, 18.5%) decreased from 67%

187 Operative mortality (p < .01) and hospital stays (p < .0

188 Observed risks of operative mortality (P=0.04) and composite outcome (P<0.

189 Number of episodes (P=0.18), operative mortality (P=0.048), stroke (P=0.126), and dis

190 However, despite higher operative mortality, patients with LFLG-AS undergoing ao

191 rative TCI rates and risk-adjusted outcomes (operative mortality, post-TCI mortality, and failure-to-

192 Operative mortality, postoperative complications, and FT

193 storic control subjects in the parameters of operative mortality, postoperative renal failure, and lo

194 r postoperative TCI rates had higher overall operative mortality ( R(2)=0.23; P=0.02) but did not hav

195 ase, the liver transplant group had a higher operative mortality rate (19%) than did either of the sh

196 epatectomy can be performed with a near-zero operative mortality rate and is associated with long-ter

197 There was a 5.3% operative mortality rate during the 22 years of the revi

198 The operative mortality rate for all patients studied was 3.

199 There is a low 5.8% operative mortality rate for patients requiring uncompli

200 during the 22 years of the review, with a 2% operative mortality rate in the last 100 patients.

201 stically improved compared with the expected operative mortality rate of 18.2% (observed-to-expected

202 Major treatment harms include an operative mortality rate of 2% to 6% and significant ris

203 was statistically equivalent to the expected operative mortality rate of 26.0% (observed-to-expected

204 omplication rate was 30.7% (n = 39), and the operative mortality rate was 0.8% (n = 1).

205 The operative mortality rate was 1.02% (16/1575) in the solo

206 Operative mortality rate was 10%, and was associated wit

207 The operative mortality rate was 10+/-3% (+/-70% confidence

208 Operative mortality rate was 10.5% (2/19), postoperative

209 The operative mortality rate was 2.2% without APBF and 5.4%

210 The 30-day operative mortality rate was 3%, with an overall actuari

211 In all Eras, the operative mortality rate was directly related to Child's

212 The operative mortality rate was higher in group 2 (7.8%) th

213 The operative mortality rate was higher with LoEF (14%) than

214 ormed for malignancy with an acceptable peri-operative mortality rate.

215 sing administrative health data, we compared operative mortality, rate of surgical complications, len

216 fewer emergency operations and lower 30-day operative mortality rates at up to 10- to 15-year follow

217 Operative mortality rates decreased for esophageal, panc

218 Operative mortality rates do not decline as surgical tra

219 Operative mortality rates for AVR, MVR, combined CABG/AV

220 d that in California during the early 1990s, operative mortality rates for esophageal, pancreatic, an

221 Operative mortality rates for pancreaticoduodenectomy ar

222 the initial studies to determine if: (a) the operative mortality rates had decreased; and (b) a great

223 Variation in post-operative mortality rates has been associated with diffe

224 bypass grafting (CABG) volume and lower CABG operative mortality rates in elderly patients.

225 We compared operative mortality rates in July relative to all other

226 hose with low procedure volumes, have higher operative mortality rates than their younger counterpart

227 Expected operative mortality rates were calculated using the Inte

228 Baseline risk profiles and expected operative mortality rates were comparable between patien

229 Adjusted operative mortality rates were lowest for cardiothoracic

230 Adjusted operative mortality rates were no higher in July than in

231 h severe AR and markedly low EF incur excess operative mortality rates, postoperative mortality rates

232 icant improvements in diagnostic imaging and operative mortality rates.

233 significant monthly or seasonal variation in operative mortality rates.

234 nformation has affected referral patterns or operative mortality rates.

235 -intervention review), and 30-day mortality (operative mortality review) after intact aneurysm repair

236 -intervention review), and 50 women (for the operative mortality review).

237 These factors can be used in determining operative mortality risk and whether elective surgical p

238 in patient SES results in a mean decrease in operative mortality risk of 7.1%.

239 Operative mortality risk was estimated statistically by

240 r, both methods modestly overestimate actual operative mortality risk.

241 Both methods modestly overestimated operative mortality risk.

242 ulmonary bypass time were linked with higher operative mortality risk; older age, emergency operation

243 transfer was not associated with a change in operative mortality (risk difference, -0.69%; 95% CI, -2

244 Black patients have higher operative mortality risks across a wide range of surgica

245 Operative mortality rose inversely with declining renal

246 esults were for esophagectomy, for which the operative mortality rose to 17.3% in low-volume hospital

247 ciety of Thoracic Surgeons Predicted Risk of Operative Mortality score (10.9% vs. 8.1%; p < 0.001) an

248 ciety of Thoracic Surgeons Predicted Risk of Operative Mortality score.

249 bid patients, etc.) can be performed with an operative mortality similar to standard sternotomy appro

250 Operative mortality steadily declined and was 2% (one of

251 There was no difference in operative mortality, sternal wound infection, or total c

252 strated decreases in expected risk of 30-day operative mortality (STS Predicted Risk of Mortality [PR

253 e women, with a median STS Predicted Risk of Operative Mortality (STS PROM) score of 7.1%.

254 After adjustment for early (operative) mortality, surgery was not associated with a

255 Endovascular repair is associated with lower operative mortality than open repair, similar mid-term m

256 embolization (PVE) had a significantly lower operative mortality than those patients without hypertro

257 Excluding operative mortalities, the median, 1-year, 2-year, and 3

258 Despite its strong association with 30-day operative mortality, the impact of older age was compara

259 % CI, 4.1%-10.3%) absolute risk reduction in operative mortality; this association persisted in the l

260 its most severe form, increases the odds of operative mortality three to eight-fold.

261 e of surgical complications (four patients), operative mortality (two patients), or ineligibility for

262 ma (PHC) is high-risk surgery, with reported operative mortality up to 17%.

263 Operative mortality was 0.6%, and postoperative and late

264 Operative mortality was 0.8% (n=10) in the MultArt and 2

265 Operative mortality was 1 of 26 patients (3.8%), dramati

266 Operative mortality was 1.4% (n = 3).

267 The operative mortality was 1.68%.

268 Overall operative mortality was 11.4% (19/167), but higher in pa

269 Operative mortality was 12% (10 of 85).

270 Operative mortality was 12/526 (2%) in the AV and 1/474

271 Operative mortality was 2.52% for CON versus 2.62% for n

272 The overall operative mortality was 2.66%.

273 The 30-day operative mortality was 2.9% ().

274 Operative mortality was 3.1% overall and was progressive

275 ital stay was 8 days, morbidity was 45%, and operative mortality was 3.1%.

276 Operative mortality was 3.4% for elective cases and 15.4

277 Ninety-day operative mortality was 3.5%.

278 Operative mortality was 3.83% for blacks versus 3.14% fo

279 Operative mortality was 3.9% for patients undergoing rep

280 Operative mortality was 3.9%.

281 Operative mortality was 7.5% but was 2.8% over the last

282 Operative mortality was 8.3% and was associated with non

283 ility of preoperative MELD scores to predict operative mortality was evaluated in subjects enrolled i

284 A significant interhospital variability in operative mortality was evident with increasing age (var

285 ion, the relationship between age and 30-day operative mortality was found to be nonlinear.

286 Operative mortality was highest in patients with acute m

287 eloped AAD late after the initial operation, operative mortality was highest in patients without preo

288 the fastest gait speed tertile (>1.00 m/s), operative mortality was increased for those in the middl

289 le analysis, the association between BMI and operative mortality was no longer significant.

290 Although peri-operative mortality was similar (2.6% vs. 2.2%, p = NS),

291 Operative mortality was similar (African American versus

292 The operative mortality was the highest in patients with pre

293 Operative mortality was zero.

294 Complications and operative mortality were evaluated for the entire cohort

295 to identify older patients at higher risk of operative mortality were greater than 74, 78, and 75 yea

296 ne the relationship between surgeon type and operative mortality while accounting for patient and hos

297 Operative mortality with high-risk surgery fell substant

298 Operative mortality with lung resection varies by surgeo

299 pital procedure volume is clearly related to operative mortality with many cancer procedures, its eff

300 Patients undergoing resection had a 9% operative mortality, with morbidity of 40%.